What Do Researchers Know about Long-Covid? - MQ Open Mind

Mental Sharpness
237 followers
Welcome to the latest episode of MQ's podcast Open Minds and Craig and I are delighted today
we've got a follow-up podcast from some of the work that MQ's been involved in with a number of
other partners in terms of the work that has started many years ago now but then looking at
the cognitive and neuropsychiatric effects of COVID-19. So welcome today we've got Professor
Paul Harrison and Paul is Professor of Psychiatry at the University of Oxford and we've also got
Max Dekay and Max is a clinical lecturer in psychiatry also at the University of Oxford. So
welcome Paul and Max to the podcast. Okay so maybe before we get into the nitty-gritty what we
normally do in the podcast is that is we say a bit about who you are so maybe Paul if I start with
you you can tell us a bit about your background how you get interested in mental health and your
sort of journey thus far in mental health research or psychiatric research. So I've been doing this
about 36 years now that feels a long time and over that time I think I've done a range I've
studied a range of disorders from Alzheimer's disease through to bipolar disorder and more
recently COVID-19 and applied a range of techniques from brain scannings and genetics through to
clinical trials and experimental meds including a current psychological treatment trial and
bipolar disorder so I'm a bit of a jack-of-all-trades. When the pandemic struck and I think like a lot of
academics our labs and our ability to do our previous research was impaired we took the
opportunity of access to some data sets to really try and explore as you've said at the beginning
the neurological and psychiatric consequences of COVID infection these latest studies are really
the latest stage that that research has got to and throughout Max has been absolutely integral
to all that work that you've done. Well that sets up really nicely then Paul for Max. I know we've
obviously we met and when we did the original podcast on the start of the study but yeah say
a bit about who you are and how you got involved in these studies. Yeah so I mean I started research
14 years ago doing my PhD in engineering and I was doing brain imaging techniques or developing
brain imaging techniques at the time and then I decided to embark on a slightly change in my career
and studied medicine in Oxford as a graduate entrance student and that's when I became
passionate about psychiatry and that's how I met Paul and I continued my interest in using
large data sets to try and answer research questions in psychiatry and so when Paul wrote me saying
that he had access to a very large and interesting data set of electronic health records data in the
US I thought it would be something that we'd be able to do with that to answer some questions
about COVID and that's how we started doing this research and then later on started
realising the limitations of electronic health records data to answer questions about COVID-19
and realising the importance of recruiting prospectively patients and participants to
fill the gaps in the knowledge of the brain consequences of COVID-19 infections.
A great, a nice summary there Max and I'd forgotten of course if you weren't,
you'd come from engineering I'd forgotten that from the previous podcast so
so welcome again to the mental health science obviously. Paul back to you then in terms of
the background of the FOSS study so can you tell us about who's funded it all that sort of stuff
and really I know there's early on in the pandemic he's published really seminal findings
and am I right in thinking this is probably the most detailed study there is out there globally
on looking at the prospective long-term impact of COVID in the context of neuropsychiatric and
neurological outcomes isn't that right? Yes I think that's probably true Rory and of course
one of the things about FOSS and COVID and the study was set up if you remember back in the
early days of the pandemic when we were all both scared and completely ignorant of what was
happening and what was going to happen I think it's real credit to the main FOSS investigators
who were centred around some chest physicians or spiritual physicians in Leicester who managed to
set up a research study at a time when we all remember the health services on its knees
to their credit that we were then able to do this study later it's also to their credit
that they didn't forget about the brain and mental health although they are chest physicians and they
wanted to measure a wide range of things for every body system they got involved with some
colleagues of mine here in Oxford and enabled us to add in not a lot but enough mental health
measures brain measures that we've been able to build on in these latest studies which we'll
come on to in a moment. The study was funded by the UKRI and the National Institute for Health
Research so I think it was recognised as being a very important priority for the UK and the NHS
health setting so the people in the study essentially all what they had in common is
they needed to go into hospital at least a day because their acute COVID was that bad.
I think it's important when we talk about the results later that that does mean we talk about
people who were that ill with their COVID initially that that was necessary. And this
is also before the vaccine this is before the vaccine of course isn't it? I was going to say
so they were both hospitalised they were first wave so the virus was in its like its original
form then and nobody had been vaccinated and so those three points it's worth bearing in mind
some of the findings may well generalise across all of COVID but I suspect other findings won't
so this is about hospitalised first wave unmedicated people if you like probably the
most severely impacted. And so that study was getting going in early 2020 through to 2021
and they recruited I think about 2,000 patients altogether and in our two studies we've been
going to talk about we've managed to study I think about 1,700 in the first study Max you'll
correct me and about 475 in the second study so those are pretty big numbers for a study that's
managed to keep in touch, follow up, recruit, consent and follow up that many people throughout
all the ups and downs of the pandemic. Yeah no it's an incredible endeavour indeed and so in
terms of the where they were recruited from Paul and that so is it Leicester only or across where
was it? Every health and every general hospital trust in the country was eligible I think the
patients recruited from dozens of trusts there were two or three that recruited many more than
others and I think Leicester and Oxford were probably the two biggest centres but it was they
went out of their way to try and be representative of the population they were recruiting so for
example they were aware of the kind of some of the ethnic inequalities in how COVID affected people's
health and I think they did all they could to try and make sure that traditionally underrepresented
populations were included. It was a challenge but I think they did a really good job getting
the context they did a good job as you could have expected them to do. Yeah and so no thanks Paul
before we move on to Max about the most recent findings is it worth you maybe just saying a bit
about what because he's published a paper I think what was the 21 or maybe it was 2020
on the sort of the key initial findings. Do you want to tell us what we what you knew what we found
out about the initial impact of COVID-19? Yes so the first paper was about five to six months later
snapshot and one of the first messages was perhaps as we now are not surprised not everyone
had recovered. An unfortunate subgroup of the people was really quite impaired across one or
more body systems and the people who are affected in one tended to be affected in several so there
was a subgroup who really were not getting better very much from their acute infection
with a range of potential what we would now call long COVID type difficulties. At the other end of
the spectrum fortunately significant proportion were largely not entirely on the route to recovery
and then a group or two groups in the middle who had sort of half from either one or the other
and that paper tried to find some of the predictors of when you were acutely or what
it was that predicted how you're going to be six months later and didn't really find very much
except perhaps the fact that how ill you'd been when you're in hospital didn't really explain it
so it wasn't for example the patients who'd gone to intensive care who were necessarily the ones
who were difficult as far as six months later. So it seemed that if you'd been enough to get
into hospital there was still a range of unexplained factors for why some people were
getting better and some weren't and as we'll hear in the most recent paper by us we've to
some extent tried to explain and I think to some extent been able to explain some of the
heterogeneity, the variation in response of people after a hospitalisation for COVID-19.
So that's really helpful. Thanks Paul and that sets up nicely then. So move to Max. Max so
the most recent paper the two to three year follow-up and that came out I think in the last
psychiatry in the last couple of weeks isn't that right in the start of August. So Johnny tell us,
I think my memory says it's the start of August, I think so. Max can you then tell us, so tell us
but first of all before we go into the findings is and as Paul alluded to at the outset obviously
you had this large sample over between 1,700 and 2,000 I think it was at the start and you've now
about just under 500 is that right in the follow-up so can you tell us a bit about how you've managed
the follow-up procedure and and how you represent if we think that those 470 whatever 500 are of
the original population and then we go on to the findings. I mean as Paul mentioned post-COVID is
an absolutely stellar study and one of the great things they've done is content people for being
re-contacted to take part in additional research. So some participants, not all of them, some
participants that agreed to be contacted didn't mean that they would agree to take part in any
additional research but it would be re-contactable so that we could ask further questions, ask them
to complete more tests and that allowed us to follow up those patients two, three years after
they were hospitalized with COVID-19 to assess their brain health in general and so we recruited,
we sent invitations to about 2,000 people and those are the 2,000 people who agreed to be
re-contacted and of those 2,000 people about 20 percent of them agreed to take part in the
research and so that raises questions about what are those 475 people, who are they compared to
those who did not respond and so everything we're going to discuss about today needs to be interpreted
with that in mind because any of the risks that we describe might not apply to the general
population. Now that being said we've tried to look at whether there was any specific differences
in those 475 people compared to all the other people who did not respond and what we've seen
is relatively small difference, we did not see anything striking, they were not particularly
younger, they were not necessarily more or less comorbidities and importantly their outcomes at
six months because many of them had provided data at six months, their depression level,
their anxiety level, their cognition at six months were not strikingly different from those who did
not respond and so that gave us some reassurance that it's not a very specific self-selected group
of people who took part in our study and might well be representative at least to some extent of
the general population of people who've been hospitalized in the UK with COVID-19. Well it's
really helpful and as you say reassuring so just to be clear then so in terms of the sub-sample
they weren't the least affected by COVID and so often we know in these studies that most people
who are most seriously unwell tend to drop out over time so it's not that that's not the case
here well it's it doesn't seem to be yeah it doesn't know of course it might be there might
be things that were not measured and that might bias this sample clearly people who were
uncertainty died as a result of COVID-19 or the ones who probably not have taken part there are
some of those clear differences but there was no clear indication that there was those were the
particularly well people or particularly unwell people the only thing we did notice is we compared
people who completed the test that we'll talk about in a minute on first invitation compared
to those who required one reminder that we sent a month after the first invitation to take part
and we thought that was a good or interesting proxy to see what about the people who did not
respond with the assumption that the people who did not respond would be more like the people
who required one reminder than those who did not require a reminder what we've seen which is quite
interesting is the people who required one reminder had similar depression level similar
anxiety level similar fatigue but had slightly worse cognition and so if anything it seems that
the people who did not take part again if we take the assumption that they are more like the people
who had one reminder would have worse cognitions than worse conditions than what we've observed
in our sample yeah that's really interesting about the sort of delayed in other areas of psychology
the delayed acceptance or the delayed acceptor type thing so that is really interesting actually
okay so moving on then max to before we get into the actual findings so what did you actually
measure what were your key outcomes and then what did you find right so we were specifically
interested in brain health and in particular in cognition and so the first thing we asked
participants to do is to complete a battery of online computerized tests of their cognition
and this gave us a fine brain assessment of their cognition in an objective way and so this is you
know this complement or extend or build upon the finding that we had for those participants in
terms of their mocha score the montreal cognitive assessment which is a pen and paper test which is
good to screen for dementia for instance but may not be so good to test cognition in people who
start with a very intact condition for whom we really want to pick up the small difference in
their cognitive ability the memory the retention and the executive function etc so that's the first
thing we did building upon our previous studies we were interested to look at the subjective
cognitive deficits of those people so people might score very well very highly on the objective
cognitive tests but they might still complain of cognitive problems they might still say that
they have difficulties remembering things communicating finding words etc and so we
asked those questions using a validated scale or subjective cognitive deficit called a cci20
and then we asked the conventional traditional or commonly used scales for depression and anxiety
so php9 and cat7 we also measured their fatigue it's not because we believe that fatigue is a
psychiatric problem or a brain problem but because it's got clear bi-directional association with
brain health we thought it was very important to measure that as well and then finally one
thing that we were very interested in in part because of our previous research based on electronic
health records that can't measure that is occupational impact we asked participants whether
they changed their occupation after they had COVID-19 compared to before they had COVID-19
and if so why did it change their occupation did they change their occupation because they were
too unwell to work or whether they retired they were made redundant etc so this is the panel of
test and questionnaires that we've asked the participants to complete okay so it really is
really comprehensive and i'm very interested to see about the occupational change then who
was having known what the findings are really interesting there as well okay so in terms of
our key what were the key take-homes then so obviously they mean really stark findings in
terms of cognitive deficits so do you want to tell us a bit about that yeah so what we found is that
one in 10 participants in our sample scored very low so to speak on the objective cognitive
deficits by that we mean that their score was two standard deviation or more below the level
at their score that we would expect for their social demographic characteristics so their age
their level of education their income etc so we were able to make that draw that conclusion from
the launch normative data set that adamshamshire had collected as part of the great british
intelligence test the study during which the uh the same questionnaires the same tests were
asked and completed by hundreds of thousands of people so two standard deviation is significant
what we also found is that in the general population so in the general cohort the mean
difference compared to what would be expected for their social demographic characteristics was
0.7 standard deviation and that corresponds we make the stretch to translate it into into an
IQ score to about 10 points 10 IQ points below um their expected level this is a difference
compared to what we would expect this does not mean that people lost 10 IQ points it might be
but because we did not have the same test before they had COVID-19 for these reasons we can't say
that this was um a change but their score at two three years after COVID-19 10 IQ points below
what we expect of them so so what would be the sort of before we go into the other findings so
what's like the practical implications of that so so what would that how would that translate in
terms of somebody's everyday life so it's it's a good question and that's one of the reasons why
we looked at um occupational impact and we can come back to that later so 10 IQ points you start
from a very high level might not be as well perceived as you start from a relatively lower
level um and so it's difficult to directly translate that into into into actually what
what it means for their everyday life and we'd not have assessments of activity of daily living
so that have things but we did have this occupational impact that was quite striking
and there's really i'm just thinking so just trying to be devil's advocate then so is there
anything in the way the IQ tests are assessed or the the cognitive ability is assessed that
actually it's a performance issue rather than a real deficit as with all intelligence tests there
could be some of those those confounding aspects one thing we did not report in the studies there
was a measure of reaction time and that reaction time we had it for people who did not have COVID-19
in the same way that we had the the total score and we didn't see striking differences it's not
that people were slower and we also applied some sort of standard quality control measures to go
to the test if people really couldn't take part in the test because they didn't understand it
or because they couldn't focus on the test and they had to sort of for instance move to another
tab in the computer and then come back to test all those results would be would be removed so
we're really looking at people who did complete the test their reaction time was quite similar
to the reaction time that we would expect yeah but they performed poorly more poorly than we
would expect them yeah okay great then moving on to the other findings max and so what are the
other outcomes in terms of maybe mental health outcomes and then we can come back to the
occupational stuff yeah so we found some some some um quite important absolute risks of depression
so we found that one in two people in our sample reported moderate to severe depression on php9
scale one in four reported moderate to severe anxiety we looked at fatigue as i said as well
so four in ten reported moderate to severe fatigue and then four in ten reported subjective cognitive
decline that we would qualify as moderate to severe as well so quite a striking number of
people two to three years after they were hospitalized with COVID-19 still report brain
health problems and fatigue yeah because just jump on there to compare that then if we look at the
studies which looked at sort of community-based samples of people's mental health and we know that
in that immediate aftermath it seems that there was obviously a decline in mental health but it
tended to recover back to whatever pre-pandemic times pretty pretty quickly so that so your sample
if i'm correct in my interpretation is they are markedly different from what we would have seen
and and people who weren't hospitalized with COVID is that right that's right i mean we did not look
at that in our study but you're bringing together yeah we've looked at that have not shown this
these striking absolute risks yeah and so maybe just before we go on to the occupational stuff
paul can i bring you back in and just maybe ask us in terms of then what do we think the mechanisms
are maybe are to to potentially explain because these are really long i mean long term effects
of over two to three years so what's our thinking along those lines well the first one just to
emphasize is because this is only a study we've had COVID we haven't for example compared them to
people of similar age and demographic and perhaps general health because we know that unfortunately
that sort of population rates of depression anxiety are higher than yeah we sometimes think
so interpreting the absolute risk in terms of what has COVID done specifically versus maybe what other
chronic illnesses or infections might have done we just need to bear that in mind having said that
i think some of ours and other people's work shows that at least some things about COVID
really are different mechanistically probably than than some of the other potential triggers
for these other difficulties and i think one of the earliest studies would suggest that small
blood clots in the brain for example may well be part of the explanation at least in some people
contributing to the cognitive deficits what i'm less clear about is is if you like the explanation
for the depression anxiety side of things i think maybe fatigue and cognition we can sort of explain
in terms of the consequences of viruses the depression anxiety to me and max you may well
have more insights is as mysterious after COVID in some ways as it is after other viral infections
chronic fatigue syndrome and other post-viral syndromes so i don't think we really have a good
handle on that i don't think really foster COVID is the ideal study to explore those
nuanced questions about mental health but again max you may have a different perspective on that
i think one thing that we've we found in our in our study is that symptoms predict each other
quite strikingly in terms of effect sizes so knowing the symptom burden of people at six months
was a very good predictor of how they were two to three years what that means is not just that
people who were depressed at six months were more likely to be depressed at two to three years
because obviously this is true but also people who had more anxiety at six months were more
likely to have depression at two to three years and people who had anxiety at six months were
fatigue at six years so they sort of predict each other in in that way again as i said in
with effect sizes are very striking so you can you can really make predictions and so it might
well be that some of the depression and anxiety that we're seeing is a byproduct of other disease
processes much like we see it in in other conditions so people have chronic conditions
Parkinson's disease diabetes are more likely to develop depression and that's perhaps due to
the effect of the chronic illness itself and it impacts the psychological impact
yeah and so we might be seeing some of that you know in our data as well yeah because
it'd be interesting even as Paul was mentioning there making comparisons with other populations
and because obviously what's the effect of hospitalization itself independent of what
the virus has been moving on then Max said to the you've alluded to the occupational finding
the change in occupation so do you want to tell us what you found because again it was
i was surprised when i read this so one of the things that we were the first thing we found is
that one in four people in our sample had changed their occupation that would mean that they had
either stopped working altogether or reduced the number of hours that they were working
working perhaps full-time and they started working part-time for instance when asked
why they changed their occupation the number one reason was poor health so this seems to be related
to COVID-19 itself and not just because they retired for instance even though some people
said they were they had retired it was a minority of people who said they had poor health the
striking thing is then we looked at which symptom at two or symptoms at two to three years
correlated with change in occupation at two to three years and i suppose i was expecting
constellation of symptoms with the people who have fatigue or anxiety depression and
cognitive deficits and and maybe some people who have several of the above would be more
likely to have cognitive deficits that would have would be more likely to change their occupation
this is not what we found what we found is that specifically the change in cognition
both the objective test the score on the objective cognitive test and the subjective
cognitive deficits were robustly and specifically associated with occupational change and what we
think that means is that's a speculation we think that means is that the reason why people change
their occupation after COVID-19 because they can't face the cognitive demands of their job
and it's not because of things like lack of motivation lack of interest lack of energy
all of which would be reflected in the php94 and for depression we did not find an association
between depression scale and change in occupation and so did this happen to do any qualitative
research on a subsample to try and explore some of those hypotheses no we didn't
and is there any any opportunity to to do so because we're interested really to
explore from the individual's point of view why they changed occupation yeah but i think there
would be a possibility to do that within FOSP again that would require doing a new prospective
study built upon the first cohort but as we said the first cohort study is designed to
to be able to do just that and i'm sure that other cohorts would be obviously would be able to do
that just as well just just add to that and i should say at the beginning the FOSP investigators
were very keen not to overburden participants and they've had a very active and appropriate
ppi involvement in designing the study so in every study they're very minded between people
like us wish to measure everything and everybody both quantitative and qualitative and the need to
ensure that participants aren't burdened so i think like everything else one has an idea for
what's doing the FOSP cohort one goes to the central trial committee and one can make the
case and then the the participants have a say in that as well so but i think as max said you
could certainly do that in this population and it would obviously as always provide an interesting
complement to the kinds of quantitative data that our study folks yeah absolutely absolutely
so thinking then the wider implications and the last time max we spoke when the findings for the
first findings came out we were talking about brain fog and as a concept and whatever so
so what do we know now about brain fog and the science of brain fog that we didn't know then or
yes maybe that's the question so have there been changes in our understanding of brain fog
is it that it's longer lasting characteristics are different what do we know now yeah well we know a
few things so we know it is longer lasting than perhaps we were hoping so after three years we
still see clear signs of of cognitive problems in people with COVID-19 who are hospitalized for it
we know it affects cognitive domains across the board so it's not as but i mean there are some
sort of differences between cognitive domains but it's not one or two cognitive domains that
really stand out and so it affects cognitive domains across the board and so that was
also in systematic reviews of prior smaller studies and then we we also know that's something
that we found in in our data that we also had some clues about in our previous study
so that subjective cognitive deficits and objective cognitive deficits do not seem to go
hand in hand so we see clear differences between between the two in their association with
biomarkers as we found in our previous study in how they are predicted by other symptoms in this
and how they evolve over time and so it seems that perhaps those are driven by a different
mechanism and might be a benefit from different different treatments yeah i mean that's a whole
it's a wider a wider question the extent to which objective and subjective measures are
tapping similar or different constructs you can probably have a whole podcast on that itself
thinking back then to the uh sort of wider implications then can we say so what we know
from the your great work so if there's a pandemic again in the morning would we would you what are
the recommendations based on your research which was you would give the government about what they
should or shouldn't do if god forbid there's another pandemic well it's obviously tempting
good party politics we're leaving that to one side i think we need we need to remember that
we were sort of misled with the covid pandemic because we'd only thought about flu pandemics
and at least some of the mistakes that were made i think can be fairly attributed to that
assumption so i think my first thing is we have to have a completely open mind when the next
apparent pandemic hits us as to what's causing it what to do about it and so that's the first
thing don't assume it's going to like covid any more than covid was like flu i think again we're
going back to where my academic hat i think seizing the opportunity early to do ethical
but decisive research is an opportunity we just can't use if the post-covid study hadn't been set
up when it was we wouldn't know any of these things and we were still wondering about what
covid was really like before it gets sort of coloured by vaccines and re-exposures and viral
drifts and all those things which are great for the population but they make it difficult
if you really want to understand what the illness is and what it might be doing to our
body systems to have an open mind but be ready amongst other things to do the appropriate
research for what appears to be emerging yeah you know complete transparency i guess i'd say
we could have done better on that on this one yeah no i think the great suggestions paul actually
max anything to add to your end that you would say recommendations to government no i would agree
with what what paul said i think the um understanding that an infection that affects
one body system might have effects on other systems and not forgetting the brain is probably
one of the key findings from mass studies and something i would advocate for strongly yeah i
think and as somebody was involved with emily holmes and many other colleagues at that start
early phase and putting together the mental health priorities covid19 priorities for mental
health science i think i mean so all do you think back to that time of how we were so we just had no
idea what was going to happen and but really pleased to be involved in that work which we
did try to prioritize not to forget the brain and mind and and mental health outcomes in terms of
wider research so thinking about we've now got the vaccine we now have different variants
of covid and i know this is this is not fair a question in some senses because it's not your
study but have we or do we know in the wider literature whether the impact of the different
variants of covid19 now are or covid it's probably no longer covid19 obviously but the the different
variants of the virus have differential neuropsychiatric effects do we know that or not
but we we looked at that in in electronic health data up until omicron so not the latest variants
and we found is that the effect on different body systems is quite clear so we looked at
across body systems not just at the effect on the brain but with a focus on the brain as well
and we found that there was quite a lot of differences in terms of things like the risk
of being admitted to icu as people knew the risk of blood clots there was no real difference in
the purely psychiatric outcomes depression and anxiety disorders so the risk of having depression
or anxiety after covid19 is about the same for the people who had were infected with omicron
or the delta variant for instance for cognitive deficits a bit different there was some clues of
a difference with less risk of omicron compared to the previous variants but that was the exception
compared to the other brain outcomes great well i didn't know you knew the answer to that max
that's a really clear answer okay so then i'll be trying to a couple of questions before we bring it
before i do that i have a couple of wider questions but there's anything about the
specific study that i haven't asked that you want to tell us about well one thing that we did find
is that and it was also surprising is that when we looked at people who had reported the same
symptoms using what are using the same scales six months 12 months and two three years we found that
overall the symptoms were worsening rather than improving and so having observed that at the
cohort level we then wondered whether this was a sign of new symptoms emerging that is people who
did not have symptoms at six and twelve months and we started having symptoms at two three years
whether there was signs of symptoms were worsening people had symptoms at six and twelve months but
those symptoms got worse at two three years we found evidence of both of those back to both
emergence of new symptoms and worsening of existing symptoms and the best explanation
we have for the emergence of new symptoms is something that we alluded to earlier which is
that people who had some symptoms in one domain say anxiety for instance at six months were then
more likely to develop new symptoms later on and so it might well be that symptoms are feeding each
other we think that might be a sign of a more complex syndrome emerging from a core set of
symptoms and if that's the case then perhaps but this is clear speculations perhaps targeting that
core symptom early would be a sustainable strategy to prevent the emergence of more symptoms later
down the line well so the to that end then have we in terms of the evidence for specific treatments
i mean has there been any any advance in how you should treat somebody then if we're trying to
ameliorate these effects is any has there any treatment studies been done to do that i'm not
aware of any but it may but i might be wrong no i'm not aware of any i know some are on the way
well at least a wider question do we need to do we need treatment specific i mean if the deficits
are things that we're aware of like anxiety depression cognitive deficits there's an
established evidence base there anyway arguably so the question was paul you're trying to come
in there anyway but i wonder do we need specific treatments that may be my question oh well there's
clearly a need as max has summarized unfortunately a significant minority at least of the people
are left with one or more serious disabilities so yes there's a need for treatment i think
both what that treatment might be and how we would test it in a rigorous way would be a real challenge
yeah if we go back to this particular group of people they're now what three three years plus
four years from their infection and we know from probably the rest of mental health rest of medicine
that once things are as ingrained as they are or evolving it's very difficult to reverse
that any effective intervention what one might want to have in place are interventions for it
and when another pandemic another wave of covid 19 happened that was making people ill enough
that you'd really want to intervene early and i think we're in a better place now than we were
then to think what those treatments might be but it's all a bit of a thought experiment i think in
terms of treatments for the unfortunate people already affected it's going to be very sort of
anecdotal and individualized rather than based on what you might call a proper clinical trial
i can't make you design that to make it both effective and ethical yeah no that's a very
important point sorry i've just got one last question so at mq we're doing a lot of research
on stress in the workplace and employee well-being so in saying that what recommendations would you
say to employers about their staff that have long covid well i think it's it's a difficult
question to answer i think the bare minimum would be to recognize that some people are struggling
after they've had covid 19 and that could that could be long lasting i think that's a bare
minimum that employers should be aware of that this is not just people pretending to be unwell
people are very unwell when we test it they're unwell when we ask validated questionnaires they're
unwell and so we have the evidence for that and this is not the only evidence that exists in terms
of specific accommodation occupational accommodation for for those people i think
as all suggested this is going to be personalized and i think it's difficult to to have a sort of
type of strategy but i think yes recognizing that the issue recognizing that some people will need
time or we need some accommodation and the workplace is important perhaps i could just
add but of course inevitably we have no idea what's going to happen next because this is the
first time this infection has affected you know us and so therefore you know things might magically
get better between three and four years they might get worse they might go on unchanged so
i think continuing follow-up of both this court and hope covid and hopefully other people experience
covid will at least give us a better sense about what the natural history is likely to be
and again i think that's going to be a challenge both for the people affected and their employers
that it's not like you're planning for coping with the stress of difficulty working now and
expecting things to be better in three months time we just don't know that so i think the good
employers are going to have to be very understanding and flexible and hopefully be aware of the evidence
that they don't make the wrong judgments about what their their employees are doing or claiming
so hopefully studies like ours can at least help provide some of the evidence to make the best
decisions for employers now great question okay so bring it to a close and two last questions
one related to what we've been talking about and then we always end with a question which is
unrelated to anything we've discussed so the related question is what do you see as a sort
of burning research question related to the broader covid 19 fields that we haven't addressed
yet and we need to address so maybe max start with you and then on to paul mechanism mechanism
we really want to uh to understand it we've got the epidemiological data now it's it's
well accumulated across many different studies across many different countries to understand
the burden that exists to understand the risk factors to understand all of that what we do
not know yet is what are the mechanisms this is obviously very difficult and this obviously takes
much more time than doing epidemiological studies where we can just access largely the sets and
analyze it but they are they are coming through there are some animal studies there are some
deep phenotyping studies that are coming through and those are very important and hopefully we
will be able to answer that that question what are the mechanisms and the plural is probably
important my my guess is that there's going to be more than one and certainly for long
but but probably also for specific symptoms of rank of it including
and understanding will hopefully lead to to effective treatments great great answer
paul same to you well i'm being boring i can max my my interest is in mechanisms and i think
heterogeneity multiple mechanisms i think we've already got hints from not well not just our
studies all the studies that there are different things going on in different people in different
body systems what i don't think we've got any sense on is how they fit together is it
that you can if you've got covid you can get one of four or five different things happen to you
or are they all interplaying is there some kind of additive effect and that's the burden to what
extent are some people biologically vulnerable to different things happening to other people
environmentally vulnerable that's really difficult as you know to put things together
to get the holistic picture it's very easy to dive into your particular molecule or
or psychological factor whatever it might be and i think being able to dive in and stand back and
is going to be a priority but let's not underestimate how difficult that is to do
in practice i like the ambition though because that's what we need of course to hopefully
if and when the next pandemic occurs so we're more they're better equipped okay so thanks
for that really wide-ranging discussion paul and max so we we end with one sort of as i said
as i mentioned a second ago an unrelated question this is always a wee bit unfair but
we go with it anyway so oh i'm going to ask you first and then max this time so if you had to
write a book tomorrow any book at all what would it be and why okay that's pretty nuanced wasn't
it it is but it's a good question i think as you i've gathered from my parents i'm reaching the
end of my career so i'm beginning to have those kind of looking back and being a grumpy old man
sort of phase and when i was when i was coming into psychiatry i wrote a short piece on i think
it's called molecules and minds and i wasn't really coming up with anything at all novel i
was just struck as i was a trainee psychiatrist the psychiatrist one the one hand meant to be
doctors with all if you like biological pharmacological prejudices that doctors
have and expertise on the other hand we're also being trained in traditional psychotherapy
and that to me is a very very different style of requirements of skills and knowledge and i
was suggesting maybe you can't expect or you shouldn't expect any one health professional
to try and be such a jack-of-all-trades and i have to say looking back on my career now i still
really worry that psychiatrists or perhaps some mental health professionals are trying to do
too many things to too many people and yet the challenge of course is always how do you then
knit together i think the phrase the mind and brain we talked about earlier seeing individual
patients i'm always struck by the need to try and produce both good medical care and good
psychological care i've had too many conversations with patients who are either naively optimistic
about the drugs i want to describe them or else nihilistic about the drugs and so get
balance right and so the integration of the psychological and the medical and by no means
the first person to think this is the challenge but you know i'd like to reflect back on whether
i think there's any better ways we can do it than we have been doing well that's a great answer i
would encourage you to write that book paul i would read it i would read it and the same question
to you max yeah it's a great question i think i'd write a book that would encourage engineers to get
interested in the mind and in psychiatry it would essentially take the form of a discussion with my
18 year old self of something who thought that you know psychology of psychiatry is not a topic
that engineers should even try to touch and because it's subjective this is messy this is etc
and actually it's probably one of the most fascinating fields in medicine if you're an
engineer to get into because there's a lot of mathematical tools that you can use there's a
lot of data there's a lot of complexity and and i think it's it's a fascinating field for
for engineers to work into and and i think the purpose of that book would be to encourage
engineer to get into psychiatry but also to make people who are like engineers or engineer minded
engineering like minded to understand mental mental illness and to understand that this is
this is these are true illnesses they can be understood in the same terms as diseases and
the fact that our social and psychological factors is no different from the rest of medicine
and explaining that in terms that engineers will understand by engineers i mean
for people who are you know working in the sort of math physics computer science engineers
fields wouldn't understand i think that would be nice but at least my 18 year old self would have
benefited from reading it and lots of 18 year old selves and others would benefit from such a book
max but i think it also speaks to the idea of you know living at the era of team science and
it's recognizing this it's a big cop on the season it's not about disciplines in that sense
so we can we've got the skills and tools to to address the right question now not tomorrow or
the day after but they are two great suggestions so thanks for for indulging me with the answer
to that question and and also behalf of craig and i huge thanks for telling us about the latest
findings from the study and and i just one last thing is i understand that by what you said i
think paul earlier or one of you said so there's going to be the continued follow-up is in on the
cards of this of this cohort is that right that's something that the phosphate obviously
the domain phosphate study based in leicester will make that determination i think that's
the intention i don't currently know for example how long the existing ethics to recontact people
goes on for but i'm sure they'll be hoping to go beyond that i think ours is the most recent
iteration of the data three years i imagine there are other similar three-year follow-ups going on
with other body systems and consequences and we were certainly keen to carry on beyond that if
great well thanks a million flat and and again huge thanks for for taking the time to to share
your insights with us today and the paper obviously is available online at lancet psychiatry
and elsewhere in the diet so huge thanks and have a great day
